Cargando…
Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323096/ https://www.ncbi.nlm.nih.gov/pubmed/37026526 http://dx.doi.org/10.1111/cas.15811 |
_version_ | 1785068894592958464 |
---|---|
author | Hanaki, Shunsuke Shimada, Midori |
author_facet | Hanaki, Shunsuke Shimada, Midori |
author_sort | Hanaki, Shunsuke |
collection | PubMed |
description | FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through the tetratricopeptide repeat domain that mediates binding to heat shock protein 90. Previous studies have reported that FKBP52 is associated with hormone‐dependent, stress‐related, and neurodegenerative diseases, revealing its diverse functions. In particular, the effects of FKBP52 on cancer have attracted considerable attention. FKBP52 promotes the growth of hormone‐dependent cancers by activating steroid hormone receptors. Recent studies have shown that the expression of FKBP52 is increased not only in steroid hormone‐dependent cancer cells but also in colorectal, lung, and liver cancers, revealing its diverse functions that contribute to cancer growth. This review summarizes reports related to hormone‐dependent cancer and cell proliferation in terms of the structure of FKBP52 and its function on interacting molecules. |
format | Online Article Text |
id | pubmed-10323096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103230962023-07-07 Impact of FKBP52 on cell proliferation and hormone‐dependent cancers Hanaki, Shunsuke Shimada, Midori Cancer Sci Review Articles FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through the tetratricopeptide repeat domain that mediates binding to heat shock protein 90. Previous studies have reported that FKBP52 is associated with hormone‐dependent, stress‐related, and neurodegenerative diseases, revealing its diverse functions. In particular, the effects of FKBP52 on cancer have attracted considerable attention. FKBP52 promotes the growth of hormone‐dependent cancers by activating steroid hormone receptors. Recent studies have shown that the expression of FKBP52 is increased not only in steroid hormone‐dependent cancer cells but also in colorectal, lung, and liver cancers, revealing its diverse functions that contribute to cancer growth. This review summarizes reports related to hormone‐dependent cancer and cell proliferation in terms of the structure of FKBP52 and its function on interacting molecules. John Wiley and Sons Inc. 2023-04-27 /pmc/articles/PMC10323096/ /pubmed/37026526 http://dx.doi.org/10.1111/cas.15811 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Hanaki, Shunsuke Shimada, Midori Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title | Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title_full | Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title_fullStr | Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title_full_unstemmed | Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title_short | Impact of FKBP52 on cell proliferation and hormone‐dependent cancers |
title_sort | impact of fkbp52 on cell proliferation and hormone‐dependent cancers |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323096/ https://www.ncbi.nlm.nih.gov/pubmed/37026526 http://dx.doi.org/10.1111/cas.15811 |
work_keys_str_mv | AT hanakishunsuke impactoffkbp52oncellproliferationandhormonedependentcancers AT shimadamidori impactoffkbp52oncellproliferationandhormonedependentcancers |